Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNF144A | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-10 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-10 |
mRNA | CBFA2T2 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-10 |
mRNA | TCEAL5 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | NEURL1B | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |